• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHC II 类转录激活因子 CIITA:不再是 NLR 蛋白中的“异类”。

The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.

机构信息

Département de Biologie, Université de Sherbrooke, 2500 Boul., Sherbrooke, QC J1K 2R1, Canada.

出版信息

Int J Mol Sci. 2021 Jan 22;22(3):1074. doi: 10.3390/ijms22031074.

DOI:10.3390/ijms22031074
PMID:33499042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7866136/
Abstract

In this review, we discuss the major histocompatibility complex (MHC) class II transactivator (CIITA), which is the master regulator of MHC class II gene expression. CIITA is the founding member of the mammalian nucleotide-binding and leucine-rich-repeat (NLR) protein family but stood apart for a long time as the only transcriptional regulator. More recently, it was found that its closest homolog, NLRC5 (NLR protein caspase activation and recruitment domain (CARD)-containing 5), is a regulator of MHC-I gene expression. Both act as non-DNA-binding activators through multiple protein-protein interactions with an MHC enhanceosome complex that binds cooperatively to a highly conserved combinatorial cis-acting module. Thus, the regulation of MHC-II expression is regulated largely through the differential expression of CIITA. In addition to the well-defined role of CIITA in MHC-II GENE regulation, we will discuss several other aspects of CIITA functions, such as its role in cancer, its role as a viral restriction element contributing to intrinsic immunity, and lastly, its very recently discovered role as an inhibitor of Ebola and SARS-Cov-2 virus replication. We will briefly touch upon the recently discovered role of NLRP3 as a transcriptional regulator, which suggests that transcriptional regulation is, after all, not such an unusual feature for NLR proteins.

摘要

在这篇综述中,我们讨论了主要组织相容性复合体 (MHC) Ⅱ类转录激活因子 (CIITA),它是 MHC Ⅱ类基因表达的主要调节因子。CIITA 是哺乳动物核苷酸结合和富含亮氨酸重复 (NLR) 蛋白家族的创始成员,但长期以来一直是唯一的转录调节因子。最近,发现其最接近的同源物 NLRC5(含有 caspase 激活和募集结构域 (CARD) 的 NLR 蛋白 5)是 MHC-I 基因表达的调节因子。两者都通过与 MHC 增强子复合物的多种蛋白-蛋白相互作用作为非 DNA 结合激活剂起作用,该复合物与高度保守的组合顺式作用模块协同结合。因此,MHC-II 表达的调节主要通过 CIITA 的差异表达来调节。除了 CIITA 在 MHC-II 基因调控中的明确作用外,我们还将讨论 CIITA 功能的其他几个方面,例如它在癌症中的作用、作为有助于固有免疫的病毒限制因子的作用,以及最近发现的作为埃博拉病毒和 SARS-CoV-2 病毒复制抑制剂的作用。我们将简要讨论 NLRP3 作为转录调节因子的新发现作用,这表明转录调节毕竟不是 NLR 蛋白的一个不寻常特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a57/7866136/11674bcf50c7/ijms-22-01074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a57/7866136/c171f5d72092/ijms-22-01074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a57/7866136/11674bcf50c7/ijms-22-01074-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a57/7866136/c171f5d72092/ijms-22-01074-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a57/7866136/11674bcf50c7/ijms-22-01074-g002.jpg

相似文献

1
The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.MHC II 类转录激活因子 CIITA:不再是 NLR 蛋白中的“异类”。
Int J Mol Sci. 2021 Jan 22;22(3):1074. doi: 10.3390/ijms22031074.
2
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.I 类转录激活物 NLRC5:MHC I 类途径和癌症免疫监视的核心参与者。
Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
3
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.FBXO11 通过泛素依赖性蛋白酶体降解 CIITA 构成 MHC Ⅱ类的主要负调控因子。
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2218955120. doi: 10.1073/pnas.2218955120. Epub 2023 Jun 6.
4
NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.NLRC5通过一个独特的SXY模块专门激活MHC I类及相关基因。
PLoS Genet. 2015 Mar 26;11(3):e1005088. doi: 10.1371/journal.pgen.1005088. eCollection 2015 Mar.
5
Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.组蛋白去乙酰化酶1/mSin3A破坏γ干扰素诱导的CIITA功能以及主要组织相容性复合体II类增强体的形成。
Mol Cell Biol. 2003 May;23(9):3091-102. doi: 10.1128/MCB.23.9.3091-3102.2003.
6
NLRC5: a newly discovered MHC class I transactivator (CITA).NLRC5:一种新发现的 MHC Ⅰ类转录激活物(CITA)。
Microbes Infect. 2012 Jun;14(6):477-84. doi: 10.1016/j.micinf.2011.12.007. Epub 2011 Dec 22.
7
Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.核苷酸结合域、富含亮氨酸重复序列的 NLR 蛋白对 I 类主要组织相容性复合物 (MHC)的调控。
J Biol Chem. 2012 Jul 13;287(29):24294-303. doi: 10.1074/jbc.M112.364604. Epub 2012 May 29.
8
CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.CIITA富含亮氨酸的重复序列控制核定位、体内募集至主要组织相容性复合体(MHC)II类增强体以及MHC II类基因的反式激活。
Mol Cell Biol. 2000 Oct;20(20):7716-25. doi: 10.1128/MCB.20.20.7716-7725.2000.
9
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.卡波西肉瘤相关疱疹病毒潜伏相关核抗原通过与调节因子X复合物结合破坏增强体组装来抑制主要组织相容性复合体II类表达。
J Virol. 2015 May;89(10):5536-56. doi: 10.1128/JVI.03713-14. Epub 2015 Mar 4.
10
Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.MHC II类反式激活因子CIITA异构体III的极端N端介导的降解、启动子招募和反式激活
PLoS One. 2016 Feb 12;11(2):e0148753. doi: 10.1371/journal.pone.0148753. eCollection 2016.

引用本文的文献

1
Combined Bioinformatics Analyses and Immunohistochemical Validation Reveal the Prognostic Relevance and Immune-Related Role of CIITA in Breast Cancer.联合生物信息学分析与免疫组织化学验证揭示CIITA在乳腺癌中的预后相关性及免疫相关作用。
J Cancer. 2025 Jul 28;16(11):3513-3524. doi: 10.7150/jca.118933. eCollection 2025.
2
T Cell Involvement in Neuroinflammation After Traumatic Brain Injury: Implications for Therapeutic Intervention.创伤性脑损伤后T细胞在神经炎症中的作用:对治疗干预的启示
CNS Neurosci Ther. 2025 Aug;31(8):e70580. doi: 10.1111/cns.70580.
3
Comprehensive insight on immune landscape in intracerebral hemorrhage patients with single-cell RNA sequencing: from blood to hematoma.

本文引用的文献

1
High MHC-II expression in Epstein-Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation.在 Epstein-Barr 病毒相关性胃癌中,MHC-II 的高表达表明肿瘤细胞在抗原呈递中起重要作用。
Sci Rep. 2020 Sep 8;10(1):14786. doi: 10.1038/s41598-020-71775-4.
2
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.MHC Ⅱ类转录激活物 CIITA 诱导细胞抵抗埃博拉病毒和 SARS 样冠状病毒。
Science. 2020 Oct 9;370(6513):241-247. doi: 10.1126/science.abb3753. Epub 2020 Aug 27.
3
RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma.
通过单细胞RNA测序对脑出血患者免疫格局的全面洞察:从血液到血肿
J Neuroinflammation. 2025 Jul 30;22(1):195. doi: 10.1186/s12974-025-03518-z.
4
Interactive effects of morphine and the HIV integrase inhibitor, cabotegravir, in male and female mice.吗啡与HIV整合酶抑制剂卡博特韦对雄性和雌性小鼠的交互作用。
Biomed Pharmacother. 2025 Mar;184:117925. doi: 10.1016/j.biopha.2025.117925. Epub 2025 Feb 24.
5
PPARδ restrains the suppression function of intra-tumoral Tregs by limiting CIITA-MHC II expression.过氧化物酶体增殖物激活受体δ通过限制II类主要组织相容性复合体反式激活因子的表达来抑制肿瘤内调节性T细胞的抑制功能。
bioRxiv. 2024 Dec 20:2024.12.16.628819. doi: 10.1101/2024.12.16.628819.
6
Adenoviral delivery of the CIITA transgene induces T-cell-mediated killing in glioblastoma organoids.腺病毒介导的CIITA转基因递送可诱导胶质母细胞瘤类器官中T细胞介导的杀伤作用。
Mol Oncol. 2025 Mar;19(3):682-697. doi: 10.1002/1878-0261.13750. Epub 2024 Nov 13.
7
CCL21 Induces Plasmacytoid Dendritic Cell Migration and Activation in a Mouse Model of Glioblastoma.CCL21在胶质母细胞瘤小鼠模型中诱导浆细胞样树突状细胞迁移和激活。
Cancers (Basel). 2024 Oct 12;16(20):3459. doi: 10.3390/cancers16203459.
8
Class II Transactivator Gene () Variants Associated with Bare Lymphocyte Syndrome II in a Female Sudanese Patient.与一名苏丹女性患者的II型裸淋巴细胞综合征相关的II类反式激活因子基因()变体
Appl Clin Genet. 2024 Sep 23;17:133-141. doi: 10.2147/TACG.S472788. eCollection 2024.
9
Aprotinin (I): Understanding the Role of Host Proteases in COVID-19 and the Importance of Pharmacologically Regulating Their Function.抑肽酶(I):了解宿主蛋白酶在 COVID-19 中的作用及药理调节其功能的重要性。
Int J Mol Sci. 2024 Jul 10;25(14):7553. doi: 10.3390/ijms25147553.
10
A Ménage à trois: NLRC5, immunity, and metabolism.三人行:NLRC5、免疫和代谢。
Front Immunol. 2024 Jul 5;15:1426620. doi: 10.3389/fimmu.2024.1426620. eCollection 2024.
RACK7 识别 H3.3G34R 突变,抑制小儿神经胶质母细胞瘤中 MHC Ⅱ类复合物成分及其递呈途径的表达。
Sci Adv. 2020 Jul 17;6(29):eaba2113. doi: 10.1126/sciadv.aba2113. eCollection 2020 Jul.
4
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma.肺癌中 MHC Ⅱ类分子在肿瘤细胞中的表达调控肿瘤免疫微环境和对 PD-1 治疗的反应
J Immunol. 2020 Apr 15;204(8):2295-2307. doi: 10.4049/jimmunol.1900778. Epub 2020 Mar 16.
5
Human Cytomegalovirus Decreases Major Histocompatibility Complex Class II by Regulating Class II Transactivator Transcript Levels in a Myeloid Cell Line.人巨细胞病毒通过调节髓系细胞系中Ⅱ类反式激活因子的转录水平来降低主要组织相容性复合体Ⅱ类分子。
J Virol. 2020 Mar 17;94(7). doi: 10.1128/JVI.01901-19.
6
Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.人类逆转录病毒感染中的限制因素和 CIITA 作为固有和适应性免疫针对 HTLV-1 的链接的空前案例。
Retrovirology. 2019 Nov 29;16(1):34. doi: 10.1186/s12977-019-0498-6.
7
A super enhancer controls expression and chromatin architecture within the MHC class II locus.超级增强子控制 MHC Ⅱ类基因座内的表达和染色质结构。
J Exp Med. 2020 Feb 3;217(2). doi: 10.1084/jem.20190668.
8
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.CIITA 驱动的 MHC Ⅱ类表达肿瘤细胞作为抗原提呈细胞的执行者:构建优化的抗肿瘤疫苗。
Front Immunol. 2019 Jul 30;10:1806. doi: 10.3389/fimmu.2019.01806. eCollection 2019.
9
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.人乳头瘤病毒阳性的头颈癌中主要组织相容性复合体II类分子的高表达表明肿瘤上皮细胞作为辅助抗原呈递细胞发挥重要作用。
Cancers (Basel). 2019 Aug 7;11(8):1129. doi: 10.3390/cancers11081129.
10
Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma.综合基因组分析确定原发性纵隔大 B 细胞淋巴瘤中的关键致病机制。
Blood. 2019 Sep 5;134(10):802-813. doi: 10.1182/blood.2019001126. Epub 2019 Jul 10.